Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (31-40 of 146) with videos related to

Pageof 15
Sort By:
Cell Cycle (Georgetown, Tex.)|June 9, 2006
CDK2 is required by MYC to induce apoptosisDebabrita Deb-Basu, Eiman Aleem, Philipp Kaldis, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
A tumor-immune mathematical model of CD4+ T helper cell dependent tumor regression by oncogene inactivationChinyere I Nwabugwu, Kavya Rakhra, Dean W Felsher, et al.
Molecular & Cellular Oncology|June 17, 2016
miR-17-92 explains MYC oncogene addictionYulin Li, Stephanie C Casey, Peter S Choi, et al.
Journal for Immunotherapy of Cancer|August 5, 2014
Oncogene withdrawal engages the immune system to induce sustained cancer regressionStephanie C Casey, Yulin Li, Alice C Fan, et al.
Plos One|September 11, 2014
Activation of Cre recombinase alone can induce complete tumor regressionYulin Li, Peter S Choi, Stephanie C Casey, et al.
Expert Opinion on Investigational Drugs|August 14, 2013
Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancerAlice C Fan, Jennifer J O'Rourke, Dave R Praharaj, et al.
Oncotarget|February 7, 2012
"Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivoBrian A DeChristopher, Alice C Fan, Dean W Felsher, et al.
Plos One|May 17, 2011
Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinomaLouis A Saddic, Stacey Wirt, Hannes Vogel, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2006
MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2Debabrita Deb-Basu, Asa Karlsson, Qing Li, et al.
Oncotarget|April 21, 2016
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemiaYulin Li, Anja Deutzmann, Peter S Choi, et al.
Pageof 15

Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Cell Cycle (Georgetown, Tex.)|June 9, 2006
CDK2 is required by MYC to induce apoptosisDebabrita Deb-Basu, Eiman Aleem, Philipp Kaldis, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
A tumor-immune mathematical model of CD4+ T helper cell dependent tumor regression by oncogene inactivationChinyere I Nwabugwu, Kavya Rakhra, Dean W Felsher, et al.
Molecular & Cellular Oncology|June 17, 2016
miR-17-92 explains MYC oncogene addictionYulin Li, Stephanie C Casey, Peter S Choi, et al.
Journal for Immunotherapy of Cancer|August 5, 2014
Oncogene withdrawal engages the immune system to induce sustained cancer regressionStephanie C Casey, Yulin Li, Alice C Fan, et al.
Plos One|September 11, 2014
Activation of Cre recombinase alone can induce complete tumor regressionYulin Li, Peter S Choi, Stephanie C Casey, et al.
Expert Opinion on Investigational Drugs|August 14, 2013
Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancerAlice C Fan, Jennifer J O'Rourke, Dave R Praharaj, et al.
Oncotarget|February 7, 2012
"Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivoBrian A DeChristopher, Alice C Fan, Dean W Felsher, et al.
Plos One|May 17, 2011
Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinomaLouis A Saddic, Stacey Wirt, Hannes Vogel, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2006
MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2Debabrita Deb-Basu, Asa Karlsson, Qing Li, et al.
Oncotarget|April 21, 2016
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemiaYulin Li, Anja Deutzmann, Peter S Choi, et al.
Pageof 15